CVE-2025-21510

Description

Vulnerability in the JD Edwards EnterpriseOne Tools product of Oracle JD Edwards (component: Web Runtime SEC). Supported versions that are affected are Prior to 9.2.9.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise JD Edwards EnterpriseOne Tools. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all JD Edwards EnterpriseOne Tools accessible data. CVSS 3.1 Base Score 7.5 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N).

Category

7.5
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.08%
Vendor Advisory oracle.com
Affected: Oracle Corporation JD Edwards EnterpriseOne Tools
Published at:
Updated at:

References

Link Tags
https://www.oracle.com/security-alerts/cpujan2025.html vendor advisory

Frequently Asked Questions

What is the severity of CVE-2025-21510?
CVE-2025-21510 has been scored as a high severity vulnerability.
How to fix CVE-2025-21510?
To fix CVE-2025-21510, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2025-21510 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2025-21510 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2025-21510?
CVE-2025-21510 affects Oracle Corporation JD Edwards EnterpriseOne Tools.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.